Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FMG Technologies is a specialized technology company that develops and commercializes Flow Micro-Gap (FMG) electrochemical reactors for the pharmaceutical and fine chemical industries. Their proprietary platform enables the scalable and sustainable synthesis of complex organic molecules, including active pharmaceutical ingredients (APIs), by leveraging advanced flow chemistry and electrosynthesis. The FMG design significantly reduces the distance between electrodes, allowing for electrolyte-free reactions and improved energy efficiency compared to traditional batch methods. The company provides both modular reactor hardware and contract process development services to help partners transition to greener, more cost-effective manufacturing processes. FMG Technologies is positioned as a key enabler of 'Green Chemistry' by reducing the reliance on toxic reagents and minimizing waste in chemical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FMG Technologies.